https://www.benchchem.com/es/product/b15603146
INS018_055 | 2828567-39-9 | TNIK/MAP4K4 Inhibitor | Best Price
Clinically validated TNIK/MAP4K4 inhibitor with Phase 2a FVC +98.4 mL improvement at 12 weeks. FDA Orphan Drug. High kinome selectivity. In stock, multiple...
tnikinhibitorbestprice